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In humans, NK cells are mainly identified by the surface expression levels of CD56 
and CD16, which differentiate between five functionally different NK cell subsets. 
However, nowadays NK cells are considered as a more heterogeneous population 
formed by various subsets differing in function, surface phenotype, and anatomic 
localization. In  human CMV- and hantaviruses-infected subjects, an increased 
frequency of a NKG2A−CD57+NKG2C+ NK cell subset has been observed, while the 
phenotype of the NK cell subpopulation associated with cancer may vary according 
to the specific kind of tumor and its anatomical location. The healthy human lymph 
nodes contain mainly the CD56bright NK cell subset while in melanoma metastatic lymph 
nodes the CD56dimCD57+KIR+CCR7+ NK cell subpopulation prevails. The five NK cell 
subpopulations are found in breast cancer patients, where they differ for expression 
pattern of chemokine receptors, maturation stage, functional capabilities. In pregnancy, 
uterine NK cells show a prevalence of the CD56brightCD16− NK cell compartment, whose 
activity is influenced by KIRs repertoire. This NK cell subset’s super specialization could 
be explained by (i) the expansion of single mature CD56dim clones, (ii) the recruitment and 
maturation of CD56bright NK cells through specific stimuli, and (iii) the in situ development 
of tumor-resident NK cells from tissue-resident CD56bright NK cells independently of the 
circulating NK cell compartment. This new and unexpected biological feature of the 
NK cell compartment could be an important source of new biomarkers to improve 
patients’ diagnosis.
Keywords: nK cells, chemokines, melanoma, anatomical distribution, diagnosis
inTRODUCTiOn
Innate lymphoid cells (ILCs) are a family of mononuclear hematopoietic cells participating to 
tissue immunity (1). Natural killer (NK) cells are prototypic members of the ILCs group 1. They 
are characterized by the capability to recognize and kill virus-infected or transformed target cells 
through a balance of activating and inhibitory signals given by different surface receptors, in the 
absence of antigen-specific priming (2). In humans, NK cells are identified by the surface expression 
of CD56 and the lack of CD3 (3). One of the first well-defined NK cell activating receptors is CD16, 
the low-affinity receptor for FcγRIII responsible for Ab-dependent cellular cytotoxicity (4). CD56 
and CD16 expression levels discriminate between five NK cell subpopulations. CD56dimCD16+ 
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NK  cells predominate in blood, at sites of inflammation, and 
show a high cytotoxic potential and broadly express MHC-
I-specific inhibitory receptors. The CD56brightCD16− and 
CD56brightCD16+ NK cell subsets predominate in lymph nodes, 
produce cytokines upon activation, express only one MHC class 
I-specific inhibitory receptor (NKG2A), display a low cytotoxic 
potential, and are considered to be a precursor of the terminally 
differentiated CD56dimCD16+ NK cells (5). CD56brightCD16+ and 
CD56−CD16+ NK cells are minor NK cell subpopulations whose 
role is largely unknown (6).
Today, based on receptor repertoire and expression levels, 
NK  cells are considered as a more heterogeneous population 
formed by various subsets differing in function, surface pheno-
type, and anatomic localization. These different NK cell subpopu-
lations are involved both in regulating physiological conditions 
and in the response against viral and tumor disease. Here, we 
review the main human NK cell subsets discovered in the context 
of infection, cancer, and pregnancy.
nATURAL KiLLeR CeLL SUBSeTS in 
HUMAn CYTOMeGALOviRUS (CMv) 
inFeCTiOn
As revealed by murine models, NK cells are essential for an 
effective defense against the herpes virus family and in particular 
against human and murine CMV (7). The co-evolution of the 
CMV and our species’ immune system is evident considering 
the virus escape strategies. Human CMV (HCMV) inhibits the 
expression of human leukocyte antigen (HLA) class I molecules, 
interfering with antigen presentation to CD8+ T cells (8). HCMV 
genome encodes for two early genes, US2 and US11, that directly 
interact with the nascent MHC-I, re-routing the molecules from 
the endoplasmic reticulum to the proteosomal compartment, 
thus preventing the correct expression of MHC-I on the infected 
cells surface (9). On the other side, HLA class I molecules loss in 
HCMV-infected cells reduces the engagement of inhibitory recep-
tors, prompting NK cell effector functions (10). However, HMCV 
expresses two late genes, UL40 and UL18, that compensate the 
loss of classical MHC-I molecules overexpressing non-classical 
MHC-I (HLA-E) (11) or directly recruiting the NK cell inhibitory 
receptor ITL-2, respectively (12).
The above described viral escape strategy is counteracted 
by our immune system due to the expansion of a specific NK 
cell subset  that actively recognizes the molecular signature of 
the HCMV escape strategy. Indeed, the main surface marker 
characterizing a specific NK cell subset in the context of HCMV 
infection is the activating receptor NKG2C, a C-type lectin 
covalently assembled with CD94 that specifically recognizes 
HLA-E molecules (13). Studies in vitro revealed that the inter-
action between peripheral blood NK cells and HCMV-infected 
fibroblasts induces the preferential proliferation of NKG2C+ NK 
cell subset through the direct involvement of the CD94/NKG2C 
receptor (14). A higher proportion of NKG2C+ NK cells after 
HCMV infection have been further observed in children with 
symptomatic congenital HCMV infection (15) and in HCMV+ 
healthy adults. In this latter case, NKG2C+ NK cells preferentially 
co-express CD57, a surface marker for highly mature NK cells, 
while they do not express NKG2A, the inhibitory counterpart 
of NKG2C. Therefore, these NK cells are a unique population 
of NKG2A.CD57+NKG2C+ NK cell clones that are absent in 
HCMV-seronegative donors (16).
Analyses performed on solid-organ transplanted (SOT) 
recipients with acute HCMV infection clarified the development 
of this subset in several discrete steps marked by the acquisition 
on the NK cell surface of a specific set of receptors: (a) increase 
of NKG2C amount, (b) acquisition of CD57 expression, and (c) 
increase of CD57 expression, resulting in the terminal full mature 
subset phenotype CD57+NKG2Cbright HMCV-associated NK cell 
subset (17). The mechanism by which this NK cell subset interacts 
with HCMV-infected fibroblast has been modeled in vitro and 
seems to involve the cell adhesion molecule CD2, a co-activating 
receptor on NK cells, and its ligand CD58. Indeed, the molecular 
interference of the CD2–CD58 interaction results in a decreased 
activation of CD57+NKG2C+ NK cells with a reduced secretion 
of TNFα and IFNγ (18).
A similar increase in NKG2C+ NK cells was observed in hemat-
opoietic cell transplantation (HCT) recipients who reactivate 
HCMV after transplantation. In this context, it has been shown 
that the NKG2A.CD57+NKG2C+ NK cells are also equipped 
with the killer cell immunoglobulin-like receptors (KIRs), which 
specifically recognize different HLA class I molecules. This lat-
ter immune phenotype feature is associated with a potent IFNγ 
secretory activity. This indicates that HCMV reactivation after 
HCT results in the expansion of a more mature and educated NK 
cell subset: NKG2A-KIRs+CD57+NKG2C+ NK cells. In addition, 
during HCMV reactivation in HCT recipients, NKG2C+ expand-
ing NK cells predominantly express KIR2DL3 (19). This NK cell 
repertoire feature is shared also by HCMV+ chronic hepatitis 
patients, where the KIR expressed on NKG2C+ NK cells is in most 
cases specific for self-HLA class I ligands, making the anti-virus 
specific NK cell subset able to discriminate between HLA-I self 
virus-infected and healthy cells (20). Moreover, in heart- and 
lung-transplanted patients, upon HCMV either reactivation or 
infection, an increased frequency of the NK cell subset express-
ing the inhibitory receptor LIR-1 recognizing the MHC class I 
homolog UL18 has been observed (21).
In HCMV+ healthy subjects, the activating KIRs (KIR2DS2, 
KIR2DS4, and KIR3DS1) also play a role in the adaptation of 
the NK cell compartment to HCMV infection. This activating 
receptor clusters mark a highly differentiated NK cell subset 
present in the periphery of HCMV+ healthy subjects regardless of 
NKG2C expression (22). The appearance and expansion of these 
NK cell subpopulations seem to be HCMV-specific, since the two 
phenomena are not induced by other human herpes viruses such 
as Epstein–Barr virus (22, 23).
A recent study demonstrated that HCMV infection was 
also related to a distinct subset of NK cells characterized by a 
deficiency in the expression of FcRγ (also known as FcεRIγ), 
associated with high amounts of NKG2C and low levels of natural 
cytotoxicity receptors NKp30 and NKp46. It is conceivable that 
this finding could be an effect of the HCMV infection. From a 
3Cristiani et al. Human NK Cell Subsets
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 656
functional point of view, this NK cell subset responds poorly to 
HCMV-infected cells directly, yet it increases its efficiency against 
infected target cells in the presence of HCMV-specific IgG. FcRγ 
deficiency and the associated phenotype seemed to be due to a 
down-modulation of the tyrosine kinase SYK, stably maintained 
through the hypermethylation of a specific region in the SYK 
promoter DNA sequences (24).
nATURAL KiLLeR CeLL SUBSeTS in 
HAnTAviRUSeS inFeCTiOn
Pathogenic hantaviruses (HTNV) are zoonotic viruses that cause 
hemorrhagic fever with renal syndrome or hantavirus pulmonary 
syndrome in humans (25). Both syndromes are characterized 
by vascular permeability and increased immune activation, 
with strong cytotoxic lymphocyte expansion of highly mature 
NKG2A−CD57+NKG2C+CD56dim NK cells (26). A deeper analy-
sis of this subset showed that it also expresses high levels of the 
early activation marker CD69, the activating NK cell receptors 
NKG2D and 2B4 and NCRs. This activated phenotype has been 
proposed to be dependent on the increased surface expression 
of IL-15 and IL-15Ra on hantavirus-infected endothelial and 
epithelial cells. On the other hand, HTNV infection weakens the 
effector responses of activated NK cells by increasing HLA class I 
expression on endothelial cells (27).
nATURAL KiLLeR CeLL SUBSeTS in 
CAnCeR
Although NK cells recognition and killing of tumor cells has 
been widely demonstrated in vitro, their in vivo activity against 
tumors remains less known. Generally, the presence of tumor-
infiltrating NK cells indicates an ongoing immune response 
against the tumor and a better prognosis; however, some reports 
suggest that it can not correlate with the prognosis or be associ-
ated with advanced disease (28). Therefore, to appreciate the real 
prognostic value of the tumor NK cell infiltrate more investiga-
tions are required.
Nowadays, phenotypically distinct NK cell populations have 
been identified in different tissues, where they could represent 
specialized subsets mediating different functions (5). The identifi-
cation and characterization of various NK cell subsets represents, 
therefore, an important advance in the understanding of tumors 
biology and could have deep implications in the monitoring and 
treatment of the disease.
In non-small cell lung cancer (NSCLC) patients, tumor-
infiltrating natural killer (TINK) cells show a very peculiar 
surface molecular pattern, with high levels of surface CD56 and 
KIRs but lack of expression of CD16. Based on its perforin con-
tent, this CD56brightCD16−KIRs+ NK cell subset seems to derive 
from peripheral CD56brightCD16−KIR− NK cells, suggesting that 
CD56brightCD16− NK cells can acquire KIRs expression within 
tumor tissues as a consequence of signals from tumor microen-
vironment (29). Another study demonstrated that TINK cells 
from NSCLC patients exhibit a significant reduction in CD11b 
and CD27 expression, two markers mainly used to distinguish 
murine NK cell subpopulations. This CD11b−CD27− subset is also 
characterized by the downregulation of CD57, CD16, DNAM-1, 
and NKp30, while CD127 and CD117 are clearly expressed, and 
NKG2A is slightly upregulated, suggesting an immature and/or 
inactive phenotype of these TINK cells (30).
In breast cancer patients, blood NK cells show strong 
alterations that became more dramatic with the advance of 
the disease. Blood NK cell compartment display a reduction in 
activating receptors (NKp30, DNAM-1, NKG2D, 2B4, CD16) 
and an upregulation of the inhibitory receptors NKG2A and 
ILT-2, which are functionally related with defective degranula-
tion and ADCC-mediated killing capabilities. These phenotypic 
and functional changes are more evident in tumor-infiltrating 
NK cells, in which a prevalence of the CD56bright compartment 
has been observed (31). Peripheral NK compartment has been 
further characterized distinguishing for the five subpopulations, 
whose proportions varying according to the disease stage. Most 
CD16+ NK cells show different combinations of KIRs except 
KIR2DL4, that in contrast is expressed on the CD56dimCD16− 
NK cell subpopulation. The CD56brightCD16− NK cell subset 
lacks the inhibitory KIRs and display low frequencies of 
KIR2DL4 and KIR2DS4, possibly indicating a reduced func-
tional ability. CD57 is strongly expressed on CD56dimCD16+ 
and CD56brightCD16+ NK cells, while is downregulated in the 
others three subsets, suggesting that they are less mature and 
differentiated. CD57 expression also correlates with perforin 
and granzyme B levels, reflecting the cytotoxic potential of the 
different NK cell subsets. The five NK cell subsets show also 
difference in the expression pattern of chemokine receptors. 
CD56dimCD16+ NK cells express CX3CR1 and CXCR1 recep-
tors, in accordance with their ability to reach inflamed tissues. 
CD56dimCD16− NK cells are characterized by CXCR1, CXCR4, 
and CD62L expression, suggesting a preferential tropism for 
both inflamed tissues and lymph nodes. CD56brightCD16− and 
CD56brightCD16+ NK cell subsets display similar patterns, 
with high levels of CCR7, CD117, and CD62L, underlying a 
favorite tropism for secondary lymphoid organs. Functionally, 
CD56dimCD16+ NK cells have the strongest cytotoxic with a 
high degranulation potential. Conversely, CD56dimCD16− and 
CD56brightCD16− NK cell subsets are poorly cytotoxic, produc-
ing low amounts IFNγ and TNFα, while the CD56brightCD16+ 
NK cell subpopulation behaves as an intermediary between 
CD56brightCD16− and CD56dimCD16+ NK cells (32).
An increase of NK cell frequency has been observed within 
the tumor-invaded lymph nodes (TILNs) of advanced stages 
melanoma patients, with a prevalence of the CD56dim NK cell 
subpopulation characterized by a high expression of CD57, 
KIRs, CD69, and the homing chemokine receptor CCR7, sug-
gesting overall a more differentiated effector phenotype actively 
migrating in the TILNs. Furthermore, peripheral blood CD56dim 
NK cell subset of these patients has an increased expression of the 
chemokine receptor CXCR2 recognizing interleukin-8, one of the 
chemokines found in TILNs (33). TILNs from melanoma patients 
also contain a peculiar CD56bright NK cell subset co-expressing 
CD16. This NK cell subpopulation has high percentages of 
TABLe 1 | Markers characterizing nK cell subset in pathological and physiological contexts.
Context Anatomical localization nK subpopulation Upregulated markers Downregulated markers Reference
Human cytomegalovirus 
infection
Peripheral blood CD56dim NKG2C
CD57
KIRs
LIR-1
NKG2A
FcRg
NCRs
(14, 16, 17, 
19–22, 24)
Human hantaviruses  
infection
Peripheral blood CD56dim NKG2C
CD57
CD69
NKG2D
2B4
NCRs
NKG2A (26, 27)
Non-small cell lung  
cancer
Tumor CD56bright NKG2A
KIRs
CD117
CD127
CD16
CD11b
CD27
CD57
DNAM-1
NKp30
(30)
Breast cancer Peripheral blood CD56brightCD16− CCR7
CD117
CD62L
KIRs
CD57
(32)
CD56brightCD16+ KIRs (except for KIR2DL4)
CD57
CCR7
CD117
CD62L
CD56dimCD16+ KIRs (except for KIR2DL4)
CD57
CX3CR1
CXCR1
CD56dimCD16− KIR2DL4
CXCR1
CXCR4
CD62L
CD57
Melanoma Tumor-infiltrated lymph node CD56dim CD57
KIR2
CD69
CCR7
(33)
CD56bright CD16
KIRs
NKp46
NKG2D
(34)
Ovarian carcinoma Peripheral blood CD56dim PD-1 NKG2A (35)
Ascites KIRs
CD57
LIR-1
CD16
NCRs
Pregnancy Uterus CD56bright NKG2A
KIRs
ILT-2
CD16 (39, 41–43, 
46).
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NKp46+, NKG2D+, and KIRs+ NK cells and increased levels 
of perforin, suggesting a more differentiated CD56bright NK cell 
subset that may exert antitumor activities (34).
Recently, a PD-1+ NK cell subpopulation has been found in 
peripheral blood and ascites from seropapillary ovarian carci-
noma patients. PD-1+ NK cells are confined to the CD56dim NK 
cell subset and are primarily composed by NKG2A−KIRs+LIR-
1+CD57+ NK cells with low levels of NCRs and high expression 
of CD16 and perforin/granzyme, indicating that PD-1 expression 
is confined to terminally differentiated NK cells. However, PD-1+ 
NK cells show a low cytolytic activity against tumor targets cells 
and are poor cytokines producers (35).
5Cristiani et al. Human NK Cell Subsets
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nATURAL KiLLeR CeLL SUBSeTS in 
PReGnAnCY
The immunological features of the placentation and pregnancy is 
another research field where the expansion of specific NK subsets 
has been appreciated to play a crucial role.
In the first trimester of pregnancy, NK cells represent the 70% 
of CD45+ decidual leukocytes together with CD8+, CD4+, γδ T 
cells, and dendritic cells. These cells are defined “uterine NK” 
(uNK, also called decidual or dNK) and play a role both in the 
success of pregnancy and in the early human immunity response 
during infections. uNK cells are predominant in non-pregnant 
endometrium, increasing and changing their morphology dur-
ing the secretory phase of the menstrual cycle (36). Prolactin 
and endometrial-derived IL-15 promote uNK cells stimulation 
and differentiation. During early pregnancy, uNK cells infiltrate 
the trophoblast supporting the placentation process. uNK cells 
control the remodeling of uterine spiral arteries, increasing 
the contact area between maternal blood and trophoblast cells 
(37, 38). uNK cells are identified by a different phenotype and 
functional characteristics compared to peripheral blood NK cells 
(pNK); they show a CD56brightCD16− phenotype and express a 
repertoire of activating and inhibitory receptors (NKRs) belong-
ing to early differentiation stages of pNK cells (39). uNK cells 
secrete vascular endothelial growth factor C, angiopoietin 2 
(ANG2), placental growth factor (PIGF), cytokines that are 
involved in angiogenesis, and that do not belong to pNK cytokine 
profile (40).
Trophoblast cells express MHC-I molecules HLA-C, HLA-E, 
and HLA-G. HLA-E has high affinity for inhibitory receptor 
CD94/NKG2A expressed by all uNK cells (41); HLA-C is rec-
ognized by KIRs receptor family whose expression is induced 
directly in utero, while HLA-G is bound by ILT-2, that is present 
on uNK cells (42), and by the activating KIR2DL4 (43). The role of 
uNK cells during pregnancy has not been completely understood, 
but the mouse is used as model due to the presence of uNK cells in 
the decidua and to the expression of MHC repertoire on tropho-
blast cells. When the MHC-I is bound to NK cell receptors, the 
uNK cells are inhibited and this interferes with fetal growth and 
remodeling of decidual spiral arteries (44). In murine pregnancy, 
only maternal MHC contributes to educate uNK cells to acquire 
functional properties, while the presence of paternal-inherited 
allogeneic MHC allele inhibits uNK cells with complications 
on both fetal growth and arterial remodeling (45). In human 
pregnancy, KIR repertoire is specific for each mother, and fetal 
HLA-C (group C1 or C2) is specific for maternal and paternal 
HLA-C contribution. The presence of maternal KIR AA haplo-
type, constituted by inhibitory KIRs genes only, is associated with 
pregnancy disorders but the risk of pre-eclampsia is increased 
when the fetus presents more C2 genes than the mother or when 
it carries a paternal HLA-C2 epitope. Instead, KIR genes that 
are protective are localized on Tel-B region of B haplotype, that 
contains the inhibitory KIR2DL5A and the activating KIR3DS1, 
KIR2DS5, and KIR2DS1. Among them, only KIR2DS1 binds to 
HLA-C, and its maternal frequency correlates with protection 
from pre-eclampsia (46).
KIR2DL4 has been proposed to favor reproduction through 
a different mechanism. This activating KIR is expressed in the 
endosomal compartment of uNK cells, where it binds and 
accumulates the soluble form of HLA-G secreted by extravil-
lous trophoblasts. KIR2DL4 engagement has been shown to 
lead to the activation of DNA damage response signaling 
pathways, resulting in the reprograming of uNK cells to a 
senescent state characterized by a very active metabolism and 
secretion of an array of soluble mediators. This regulated and 
sustained secretory response would shape and remodel the 
local environment to increase vascularization required for a 
growing fetus (43).
It has been shown that uNK cells have the capability to control 
HCMV infection, and actually they acquire cytotoxic phenotype 
against HCMV-infected decidual fibroblasts in  vitro, modulat-
ing their receptor repertoire. NKG2D and CD94/NKG2C have 
an important role in uNK cell response, also demonstrated by 
cytokine production. Moreover, uNK cells are also able to infil-
trate HCMV-infected tissues and to generate an immunological 
synapse. Further investigations are needed to characterize the 
innate immune defense mechanisms in controlling viral response 
during pregnancy in vivo (47).
COnCLUSiOn
The deep and new knowledge on the composition of the human 
NK cell compartment reveals a more complex landscape than 
that appreciated before. Here, we gave an overview of the 
NK  cell   subsets enter recruited in specific pathological and 
physiological conditions (Table  1). This NK cell subsets’ super 
specialization could be possibly explained at least in the following 
three ways:
(1) ontogenetically determined mature CD56dim NK cell sub-
sets, arising from the circulating or secondary lymphoid 
tissues NK cell population in humans and equipped with 
clonally distributed activating and inhibitory NK cell 
receptors repertoire, scrutinize our tissues continuously 
preserving our body homeostasis. When the single NK cell 
subset equipped with the appropriate receptor/s to recog-
nize the pathological associated molecular pattern is called 
in action as effector or regulatory cells upon the pathological 
stimulation, it will expand as classically described in mouse 
upon MCMV infection (48), in a process reminiscent of the 
adoptive immune memory.
(2) CD56bright immature NK cells are recruited in the lymph 
nodes, other secondary lymphoid organs or inflammated 
tissues where they are exposed to stimuli that induce their 
activation and maturation, i.e., cytokines, cell-to-cell inter-
actions, and chemokine stimulation. The different combina-
tions of biological stimuli will dictate the maturation toward 
a given subset.
(3) Tumor-resident NK cells could develop locally from tissue-
resident CD56bright NK cells independently of the circulating 
NK cell compartment, likely due to the organ and/or tumor 
microenvironment (49).
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